Real-time enrollment status for this idiopathic pulmonary fibrosis clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 4:53 AM UTC
| NCT Number | NCT06567717 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic Pulmonary Fibrosis |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Cedars-Sinai Medical Center |
| Last Updated on CT.gov | November 10, 2025 (Nov 10, 2025) |
As of July 14, 2026: Clinical trial NCT06567717 is currently recruiting participants. This phase2 study for idiopathic pulmonary fibrosis is actively seeking new participants at 1 location across the United States. The study is sponsored by Cedars-Sinai Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06567717 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06567717 was last updated Nov 10, 2025 (November 10, 2025). HelloStudys verifies this status automatically.